Rob Woodman, formerly a senior partner at Takeda’s CVC unit and head of its Genesis Labs incubator, will lead venture firm Panakès Partners’ biotech investment activities.
Rob Woodman has departed from Takeda Ventures, the corporate venture capital (CVC) arm of pharmaceutical firm Takeda, and joined Italy-headquartered venture capital firm Panakès Partners.
Takeda Ventures hired Woodman in 2018 as a UK-based senior partner and head of Genesis Labs, the corporate’s research and development-focused internal incubator scheme. His role included leading investments in, and joining the boards of companies including Transine Therapeutics and Catamaran Bio.
Woodman has taken a partner role at Panakès Partners and will…
